Barr Pharmaceuticals/PLIVA - Knowledge Source Spotlight

Barr Pharmaceuticals/PLIVA
Keywords: profiles, competitive, market, strategic, business, industry, healthcare, size

Full Report Price: 0.00
Delivery: Immediate Online Access
Publication Date: 25-FEB-07
Pages: 1
Format:

Report Description

Barr Pharmaceuticals' subsidiary PLIVA received final approval from the FDA for its Abbreviated New Drug Application to manufacture and market Sertraline Hydrochloride Tablets, 25 mg, 50 mg and 100 mg, generic versions of Pfizer Inc.'s ZOLOFT(R) Tablets.


Knowledge Source Research Products
	Browse other Knowledge Source industry research products: Health Care Market Overviews BusIntell Reports Spotlight
About Knowledge Source
	Knowledge Source On-Line, since 1989, has delivered healthcare business information and analyses services to executives who seek a competitive edge. Knowledge Source provides healthcare information, syntheses, analysis and presentation services to busy managers who seek actionable market knowledge about clients, competitors, industries or markets in a world with an over-abundance of data.